Free Trial
→ Many investors are about to lose everything (From Porter & Company) (Ad)tc pixel
OTCMKTS:SQZB

SQZ Biotechnologies Earnings Date & Estimates

$0.02 0.00 (0.00%)
As of 11/9/2026

SQZ Biotechnologies is estimated to report earnings on Thursday, November 12, 2026.

Research:Profile

Upcoming Earnings Announcement

Announcement Date
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from SQZ Biotechnologies

SQZ Biotechnologies is expected to post earnings of -$0.5825 per share on revenue of $4.66 million. SQZ Biotechnologies last reported on November 8, 2023, posting -$0.54 per share and beating the -$0.66 consensus estimate. SQZ Biotechnologies has beaten the consensus EPS estimate in 6 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.5825
Expected Revenue
$4.66 million

Recent Track Record

Last Reported
Q3 2023
Last Quarter EPS
-$0.54 (Beat by +$0.12)
EPS Beat Rate
6 of last 8 quarters

Prepare for the Earnings Call

SQZ Biotechnologies Earnings FAQ

SQZ Biotechnologies (OTCMKTS:SQZB) is estimated to report earnings on Thursday, November 12, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Analysts expect SQZ Biotechnologies to post earnings of -$0.5825 per share for the quarter.

The consensus revenue estimate for SQZ Biotechnologies is $4.66 million for the quarter.

SQZ Biotechnologies Earnings Headlines

SQZ Biotechnologies (SQZB) Projected to Release Quarterly Earnings on Thursday
November 5, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31180054
SQZ founder's new startup goes from zero to $1M in revenue in a year
December 19, 2024  |  bizjournals.comhttps://www.bizjournals.com/boston/news/2024/12/19/portal-bio-seed-round.html
Executive Order 14241 Unleashes Trump’s New Dollar
A landmark executive order, 14241, is reportedly set to reshape how Americans use money starting this December. The agenda at the upcoming G20 Summit in Miami has shifted, and new research points to a major monetary announcement from President Trump. A new documentary breaks down what this shift could mean for savings, investments, and the assets tied to it.tc pixel
November 10 at 1:00 AM  |  Porter & Company (Ad)
SQZ Biotechnologies (OTC:SQZB) Stock, Short Interest Report
October 6, 2024  |  benzinga.comhttps://www.benzinga.com/quote/SQZB/short-interest
Introducing Portal Biotechnologies
December 12, 2023  |  businesswire.comhttps://www.businesswire.com/news/home/20231212550177/en/Introducing-Portal-Biotechnologies
See More SQZ Biotechnologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like SQZ Biotechnologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SQZ Biotechnologies and other key companies, straight to your email.

About SQZ Biotechnologies

SQZ Biotechnologies (OTCMKTS:SQZB) Co. was a biotechnology company that developed cell therapies using its proprietary Cell Squeeze technology. The platform was designed to deliver biological materials, including proteins, nucleic acids and other therapeutic payloads, directly into cells while preserving cell viability and function.

The company focused primarily on oncology and immunology applications. Its research programs included engineered immune-cell therapies intended to stimulate anti-tumor responses, including programs involving antigen-presenting cells and peripheral blood mononuclear cells. SQZ Biotechnologies also evaluated potential applications in infectious diseases and other conditions involving immune-system regulation.

Founded in 2013 and headquartered in Cambridge, Massachusetts, the company conducted research and development activities in the United States. Armon Sharei, a co-founder, served as its chief executive officer for much of its public-company history. SQZ Biotechnologies later announced plans to wind down its operations, and publicly available information about its ongoing business activities is limited.

View SQZ Biotechnologies Profile
Earnings Tools